Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Arenas

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Antioxidants (Basel, Switzerland)|October 27, 2019
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox TherapyAlba Rodríguez-García, María Luz Morales, Vanesa Garrido-García, et al.
Scientific Reports|December 11, 2019
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemiaMaría Luz Morales, Alicia Arenas, Alejandra Ortiz-Ruiz, et al.
Molecular Diagnosis & Therapy|September 3, 2020
Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia PatientsAlicia Arenas Cortés, Susana Olmedillas, Juana Serrano-López, et al.
Plos One|July 14, 2017
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, et al.
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Antioxidants (Basel, Switzerland)|October 27, 2019
Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox TherapyAlba Rodríguez-García, María Luz Morales, Vanesa Garrido-García, et al.
Scientific Reports|December 11, 2019
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemiaMaría Luz Morales, Alicia Arenas, Alejandra Ortiz-Ruiz, et al.
Molecular Diagnosis & Therapy|September 3, 2020
Comparison of Droplet Digital PCR versus qPCR Measurements on the International Scale for the Molecular Monitoring of Chronic Myeloid Leukemia PatientsAlicia Arenas Cortés, Susana Olmedillas, Juana Serrano-López, et al.
Plos One|July 14, 2017
PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phaseJuan M Alonso-Dominguez, Luis Felipe Casado, Eduardo Anguita, et al.
Genes & Diseases|November 11, 2025
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomasSara Mellid, Eduardo Caleiras, Ángel M Martínez-Montes, et al.
Pageof 5